Multiple myeloma and human immunodeficiency vivus-1 (HIV-1) infection

Citation
Tt. Yee et al., Multiple myeloma and human immunodeficiency vivus-1 (HIV-1) infection, AM J HEMAT, 66(2), 2001, pp. 123-125
Citations number
14
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
AMERICAN JOURNAL OF HEMATOLOGY
ISSN journal
03618609 → ACNP
Volume
66
Issue
2
Year of publication
2001
Pages
123 - 125
Database
ISI
SICI code
0361-8609(200102)66:2<123:MMAHIV>2.0.ZU;2-Y
Abstract
Multiple myeloma (MM) in three human immunodeficiency Virus (HIV)-infected patients is reported. HIV infection predisposes to the development of high- grade B-cell lymphomas, but few cases of plasma cell tumours in association with HIV have been reported. The coincidence of HIV infection and neoplasi a highlights the distinct roles of immunodeficiency and infection with herp esviridae, including HIV itself, in the pathogenesis of HIV-related tumours , In addition, a number of cytokines (e.g,, interleukin-6 [IL-6]) and angio genic factors (e.g., vascular endothelial growth factor [VEGF] and basic fi broblastic growth factor [bFGF]) may play a role in the initiation, mainten ance, and progression of multiple myeloma (MM), Infection was the first cli nical consideration to the cause of the illness in two of our HIV-seroposit ive patients. The diagnosis of MM may be difficult in patients with advance d HIV infection as they often have renal failure, bone marrow plasmacytosis , repeated infections, and polyclonal hypergammaglobulinaemia, due to HIV i nfection itself, opportunistic pathogens, and/or medication, (C) 2001 Wiley -Liss, Inc.